🇺🇸 FDA
Patent

US 11766403

Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders

granted A61KA61K31/573A61K38/08

Quick answer

US patent 11766403 (Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders) held by United States Government as represented by the Department of Veterans Affairs expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/573, A61K38/08, A61K45/06, A61K47/42